Arch Therapeutics Inc (ARTH) financial statements (2021 and earlier)

Company profile

Business Address 235 WALNUT STREET, SUITE 6
FRAMINGHAM, MA 01702
State of Incorp. NV
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8799592,1804,6675,9945,0363,960
Cash and cash equivalents8799592,1804,6675,9945,0363,960
Inventory, net of allowances, customer advances and progress billings1,016968347    
Inventory1,016968347    
Prepaid expense   152   
Other undisclosed current assets197216363 8510843
Total current assets:2,0922,1432,8904,8196,0795,1444,003
Noncurrent Assets
Property, plant and equipment45917744
Other noncurrent assets44444  
Other undisclosed noncurrent assets     (4)(4)
Total noncurrent assets:88132111  
TOTAL ASSETS:2,1002,1512,9024,8406,0905,1444,003
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities391342534161265680232
Accounts payable391342534161265375232
Interest and dividends payable     305 
Debt5737   900474
Derivative instruments and hedges, liabilities      335
Other undisclosed current liabilities294267180127169299245
Total current liabilities:7426467142884341,8791,286
Noncurrent Liabilities
Long-term debt and lease obligation     78967
Long-term debt, excluding current maturities     78967
Liabilities, other than long-term debt2,2072,3162,9963,1923,43026210
Accounts payable and accrued liabilities     26210
Derivative instruments and hedges, liabilities2,2072,3162,9963,1923,430  
Other undisclosed noncurrent liabilities1,719689     
Total noncurrent liabilities:3,9273,0052,9963,1923,4301041,177
Total liabilities:4,6693,6523,7103,4803,8641,9832,463
Stockholders' equity
Stockholders' equity attributable to parent(2,569)(1,500)(807)1,3602,2273,1611,540
Common stock193193173160150134107
Additional paid in capital41,94941,86337,88535,51731,58024,74117,155
Accumulated deficit(44,711)(43,556)(38,865)(34,317)(29,503)(21,715)(15,722)
Total stockholders' equity:(2,569)(1,500)(807)1,3602,2273,1611,540
TOTAL LIABILITIES AND EQUITY:2,1002,1512,9024,8406,0905,1444,003

Income statement (P&L) ($ in thousands)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Operating expenses(5,014)(5,371)(6,372)(7,450)(7,303)(6,051)(5,461)
Operating loss:(5,014)(5,371)(6,372)(7,450)(7,303)(6,051)(5,461)
Interest and debt expense    (131)(277)(378)
Loss before gain (loss) on sale of properties:(5,014)(5,371)(6,372)(7,450)(7,434)(6,327)(5,838)
Other undisclosed net income406679     
Net loss:(4,608)(4,691)(6,372)(7,450)(7,434)(6,327)(5,838)
Other undisclosed net income (loss) attributable to parent423 1,8242,636(355)3352,891
Net loss available to common stockholders, diluted:(4,186)(4,691)(4,548)(4,814)(7,789)(5,992)(2,948)

Comprehensive Income ($ in thousands)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net loss:(4,608)(4,691)(6,372)(7,450)(7,434)(6,327)(5,838)
Comprehensive loss, net of tax, attributable to parent:(4,608)(4,691)(6,372)(7,450)(7,434)(6,327)(5,838)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: